Squarepoint
ZLAB icon

Squarepoint’s Zai Lab ZLAB Stock Holding History

Squarepoint’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Sell
15,316
-4,147
-21% -$81.9K ﹤0.01% 3826
2026
Q1 		$366K Buy
+19,463
New +$361K ﹤0.01% 3554
2025
Q1 		– Sell
-27,961
Closed -$732K – 5556
2024
Q4 		$732K Buy
+27,961
New +$776K ﹤0.01% 3364
2023
Q3 		– Sell
-26,897
Closed -$746K – 4330
2023
Q2 		$746K Buy
+26,897
New +$880K ﹤0.01% 2379
2023
Q1 		– Sell
-16,085
Closed -$494K – 3897
2022
Q4 		$494K Buy
+16,085
New +$507K ﹤0.01% 2297
2022
Q1 		– Sell
-8,193
Closed -$515K – 3634
2021
Q4 		$515K Sell
8,193
-10,371
-56% -$879K ﹤0.01% 2128
2021
Q3 		$1.96M Sell
18,564
-218
-1% -$31.3K 0.01% 1212
2021
Q2 		$3.32M Buy
18,782
+14,001
+293% +$2.25M 0.01% 916
2021
Q1 		$638K Buy
+4,781
New +$740K ﹤0.01% 1843
2020
Q2 		– Sell
-5,532
Closed -$285K – 2562
2020
Q1 		$285K Buy
+5,532
New +$288K 0.01% 1318
2019
Q1 		– Sell
-8,774
Closed -$204K – 2488
2018
Q4 		$204K Sell
8,774
-3,399
-28% -$63K ﹤0.01% 1680
2018
Q3 		$237K Buy
+12,173
New +$264K ﹤0.01% 1673

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Squarepoint's ZLAB Position: Q2 2026 in Review

Squarepoint reduced its Zai Lab (ZLAB) stake by 21% in Q2 2026, selling an estimated $81.9K and leaving 15,316 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Squarepoint first reported a position in ZLAB in Q3 2018 and has held it in 12 quarters since. The position peaked at $3.32M in Q2 2021. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Squarepoint held 15,316 shares of Zai Lab worth $291K as of Q2 2026.
  • Squarepoint sold 4,147 Zai Lab shares in Q2 2026, an estimated $81.9K.
  • Zai Lab made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3826 holding.
  • Squarepoint first reported a position in Zai Lab in Q3 2018 and has held it in 12 quarters since.
  • Squarepoint's Zai Lab position peaked at $3.32M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.